Pioglitazone and Risk for Bone Fracture: Safety Data From a Randomized Clinical Trial

CONTEXT: Pioglitazone reduces cardiovascular risk in nondiabetic patients after an ischemic stroke or transient ischemic attack (TIA) but is associated with increased risk for bone fracture. OBJECTIVE: To characterize fractures associated with pioglitazone by location, mechanism, severity, timing, a...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Clin Endocrinol Metab
Hoofdauteurs: Viscoli, Catherine M., Inzucchi, Silvio E., Young, Lawrence H., Insogna, Karl L., Conwit, Robin, Furie, Karen L., Gorman, Mark, Kelly, Michael A., Lovejoy, Anne M., Kernan, Walter N.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Endocrine Society 2016
Onderwerpen:
Clinical Research Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5460686/
https://ncbi.nlm.nih.gov/pubmed/27935736
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2016-3237
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items